SR One Capital Management’s Post

Alberto Loche and I had the great honor to convene the McKinsey CGT expert panel at the #jpm2024 conference with Lynelle Hoch (BMS), Jak Knowles (Affini-T Therapeutics), Fabian Gerlinghaus (Cellares), Peter Olagunju (March Biosciences), and Cindy Perettie (Kite, A Gilead Company). Thanks all for such an insightful discussion and stay tuned for more insights coming out soon! #biotech #CGT #innovation #mckinseyinsights

I'm continually impressed by the incredible progress of VK2809, by Viking Therapeutics, Inc.. As they continue to innovate, a purpose-driven brand strategy can amplify their impact even further. Let's connect to explore how we can elevate this remarkable product to new heights! #Pharma #Biotech #MedDevice #BrandStrategy #PurposeDriven #AmplifyYourVoice #NASH #AddisonWhitney

🚨 Aerovate Therapeutics Stock Downgraded 🚨 Aerovate Therapeutics stock has been downgraded by BTIG following a setback in the AV-101 trial. Mixed analyst views are emerging, making future pivotal readouts crucial for investors. 📉🔍 #Biotech #Investing #StockMarket #Healthcare #Pharma #ClinicalTrials #InvestmentNews #StockUpdate https://lnkd.in/dnkX2JEe

🚀 Discover the latest achievements & breakthroughs from our #Portfolio companies. #Ysiosportfolio

Thoughts on this? >> Rona Therapeutics raises $35M; Actuate now plans for $22M IPO >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #productmarketing #biotech #healthcare #pharma

Did you hear that we recently acquired AbCheck s.r.o.? Learn more about the acquisition and how it boosts our Address, Navigate, Determine (AND)™ Platform and enhances our ability to generate multiple AND-Body™ Therapeutics in parallel: https://bit.ly/47AA18g #Biotechnology #Healthcare #DrugDiscovery #DrugDevelopment

Thoughts on this? >> Rona Therapeutics raises $35M; Actuate now plans for $22M IPO >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #biotech #pharma #pharmaceutical #healthcare

Exciting update! Venkat Nelabhotla, the CEO at Vyome Therapeutics, Inc., is going to be a keynote speaker at our 7th Annual Drug Discovery Summit, Princeton,NJ. Grab your spot now by reaching out to- Sid@alcor-wealth.com. Be a part of this awesome summit where we dive deep into the world of drug discovery. #ADDP #DrugDiscovery #Innovation #Summit2024 #biotechnology Secure your spot and let's make this summit a blast! 🚀

Dr. Terri Gaskell, CTO of Rinri Therapeutics, shares her insights on developing and manufacturing a PSC therapeutic at IMAPAC Biomanufacturing 5.0 conference today in London. Her advice? Begin with the end in mind. Don't just focus on what is acceptable in a First-In-Human (FIH) trial, but consider what will likely change to generate a commercial product. Dr. Gaskell emphasizes the importance of collecting everything while developing your manufacturing process. This will facilitate retrospective analysis and help you identify areas for improvement. Additionally, it's crucial to know the sensitivity, robustness, and limitations of your tools. Rely on them only as much as justified. Bank sufficient material to validate your assays if justified in risk assessment. Remember, developing a successful commercial product requires thoughtful planning and attention to detail. Thank you, Terri, for sharing your valuable insights. #productdevelopment #manufacturingprocess #commercialproduct #biotech #advancedtherapies #PSC

Thoughts on this? >> Clasp Therapeutics emerges with $150M based on work from Bert Vogelstein, Drew Pardoll >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #productmarketing #pharma #biotech